Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$668.58 USD

668.58
1,298,850

+5.33 (0.80%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $667.86 -0.72 (-0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (76 out of 244)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

McKesson's (MCK) Latest JV to Boost Cancer Treatment Options

by Zacks Equity Research

McKesson's (MCK) latest activities in the oncology care space is expected to serve a wider patient pool.

Zacks Equity Research

McKesson (MCK) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, McKesson (MCK) closed at $314.66, marking a +1.16% move from the previous day.

Zacks Equity Research

McKesson (MCK) Gains As Market Dips: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed the most recent trading day at $311.05, moving +0.54% from the previous trading session.

Zacks Equity Research

McKesson (MCK) Stock Moves -1.19%: What You Should Know

by Zacks Equity Research

In the latest trading session, McKesson (MCK) closed at $304.02, marking a -1.19% move from the previous day.

Zacks Equity Research

McKesson (MCK) Gains But Lags Market: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed the most recent trading day at $307.68, moving +0.38% from the previous trading session.

Zacks Equity Research

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

by Zacks Equity Research

Sector ETF report for PPH

Zacks Equity Research

McKesson (MCK) Stock Moves -0.95%: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed at $312.03 in the latest trading session, marking a -0.95% move from the prior day.

Zacks Equity Research

Here's Why You Should Retain McKesson (MCK) Stock Right Now

by Zacks Equity Research

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

Zacks Equity Research

Is First Trust Consumer Staples AlphaDEX ETF (FXG) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FXG

Zacks Equity Research

Should You Invest in the First Trust Consumer Staples AlphaDEX ETF (FXG)?

by Zacks Equity Research

Sector ETF report for FXG

Sweta Killa headshot

5 Stocks in S&P 500 ETF Defying Losing Streak Since 2011

by Sweta Killa

While most of the stocks in SPY's portfolio are deep in red, a few have outperformed so far this year, with energy stocks being the biggest gainers.

Zacks Equity Research

McKesson (MCK) Q4 Earnings Miss, Revenues Beat Estimates

by Zacks Equity Research

McKesson's (MCK) fiscal fourth-quarter 2022 results benefit from segmental growth.

Zacks Equity Research

McKesson (MCK) Lags Q4 Earnings Estimates

by Zacks Equity Research

McKesson (MCK) delivered earnings and revenue surprises of -3.80% and 3.74%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Debanjana Dey headshot

Medical Product Stocks' Earnings May 5 Roster: MCK, CAH & PODD

by Debanjana Dey

The Medical Product companies' quarterly results are likely to reflect base business recovery. Let's see how MCK, CAH and PODD are poised ahead of their earnings releases.

Zacks Equity Research

McKesson (MCK) to Report Q4 Earnings: What's in the Cards?

by Zacks Equity Research

McKesson's (MCK) fiscal fourth-quarter results are likely to reflect the solid show by the U.S. Pharmaceutical and Specialty Solutions segment.

Zacks Equity Research

Should IQ Chaikin U.S. Large Cap ETF (CLRG) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for CLRG

Zacks Equity Research

McKesson (MCK) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

McKesson (MCK) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

McKesson (MCK) closed the most recent trading day at $317.31, moving -0.27% from the previous trading session.

Zacks Equity Research

Is IQ Chaikin U.S. Large Cap ETF (CLRG) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for CLRG

Zacks Equity Research

McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?

by Zacks Equity Research

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

Zacks Equity Research

Illumina (ILMN) Hurt by Rising Costs, Tough Competition

by Zacks Equity Research

Regulatory complications are raising the legal expenses for Illumina (ILMN), thereby building pressure on the bottom line.

Zacks Equity Research

Here's Why You Should Retain Phibro (PAHC) Stock For Now

by Zacks Equity Research

Investors are optimistic about Phibro (PAHC) owing to the robust performances by its Animal Health and Mineral Health segments.

Zacks Equity Research

Integer Holdings' (ITGR) Latest Buyout to Expand Its Footprint

by Zacks Equity Research

Integer Holdings' (ITGR) buyout of Aran Biomedical is set to expand its presence in high-growth markets as well as enhance its product offerings.

Zacks Equity Research

Masimo's (MASI) Sound United Buyout to Boost Product Portfolio

by Zacks Equity Research

Masimo's (MASI) completion of Sound United's buyout to help enhance the former's extended portfolio of hospital and home medical technology solutions.

Zacks Equity Research

Illumina (ILMN) Launches Genomic Solution Hub in Brazil

by Zacks Equity Research

Illumina's (ILMN) customers and partners in Brazil currently span basic research, applied markets to clinical labs and healthcare institutions.